Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2020-02-18 Legal Proceedings Report
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Postanowienie o oddaleniu zażalenia Bioton S.A. na postanowienie Sądu Rejonowego dla m.st. Warszawy w Warszawie o wyznaczenie rewidenta do spraw szczególnych - Content (PL)
Legal Proceedings Report Classification · 95% confidence The document text is a short announcement from the Management Board of Bioton S.A. regarding a court decision (Sąd Okręgowy w Warszawie) concerning the appointment of a special auditor (rewidenta do spraw szczególnych). This concerns a legal/regulatory matter involving the company and the court system. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It specifically details an update on a legal proceeding or regulatory action related to corporate governance/auditing oversight. Given the options, 'Legal Proceedings Report' (LTR) is the most appropriate fit as it relates to a significant legal/court development affecting the company's structure or operations, even if it's not a traditional lawsuit. It is too specific for the general 'Regulatory Filings' (RNS) fallback.
2020-02-18 Polish
Terminarz publikacji raportów okresowych BIOTON S.A. w roku 2020 - Content (PL)
Report Publication Announcement Classification · 98% confidence The document explicitly outlines the schedule for the company's periodic reports (quarterly, semi-annual, and annual reports) for the year 2020, including specific dates for release (e.g., 30.04.2020, 31.08.2020, 14.04.2020). It also cites specific Polish Ministry of Finance regulations regarding the content and timing of these reports. This is a formal announcement detailing *when* reports will be published, rather than the reports themselves. Since it is an announcement about the publication schedule of various financial reports (quarterly, semi-annual, annual), the most fitting category is Report Publication Announcement (RPA). It is not a general regulatory filing (RNS) because RPA is more specific to report timing announcements.
2020-01-31 Polish
Zawarcie umowy cesji (Novation Agreement) - Content (PL)
Regulatory Filings Classification · 95% confidence The document text describes a significant contractual change: the assignment (novation) of a Global Exclusive License Framework Agreement concerning product import and distribution rights. It details the parties involved (Bioton, Cedent, Cesjonariusz), the effective dates, the duration of the new agreement (15 years + 5 years option), termination clauses, governing law (Singapore), and provides an estimated financial impact (250 million PLN over 3 years). This type of material event, which significantly impacts business operations and future revenue streams, is typically disclosed as a major corporate event or transaction. Since it is not a standard financial report (10-K, IR, ER), nor a management change (MANG), nor a dividend announcement (DIV), it best fits the category for significant corporate transactions or material agreements. Given the provided definitions, this relates most closely to a major business agreement/transaction, which often falls under general regulatory announcements or specific transaction reports. Since there is no specific 'Material Contract' code, and it details a significant business development that is not explicitly covered by other codes (like M&A, Financing, or Director Dealing), it should be classified as a general Regulatory Filing (RNS) or potentially a Legal/Contractual update (LTR). However, LTR is defined as 'Legal Proceedings Report' (lawsuits/regulatory actions), which this is not. Therefore, RNS (Regulatory Filings / miscellaneous filings) is the most appropriate fallback for a material contract update that doesn't fit elsewhere.
2020-01-16 Polish
Zawarcie Wiążacego Listu Intencyjnego z Harbin Gloria Pharmaceuticals Co., Ltd. - Content (PL)
Legal Proceedings Report Classification · 99% confidence The document text is a formal announcement by the Management Board (Zarząd) of BIOTON S.A. regarding receiving a Binding Letter of Intent (Wiążący List Intencyjny - WLI) concerning a settlement agreement (ugoda) related to past disputes arising from a Distribution Agreement (Umowa Dostawy i Dystrybucji - UDD). This involves a financial settlement ($9 million USD) and the resolution of potential arbitration proceedings. Since the content directly addresses a significant legal/dispute resolution matter involving financial consequences and the potential initiation of arbitration, it falls under the category of reporting on significant legal proceedings or related settlements. This aligns best with the Legal Proceedings Report (LTR) definition, which covers significant lawsuits, regulatory actions, or legal matters.
2020-01-13 Polish
Oświadczenia Członków Rady Nadzorczej Bioton S.A. - Content (PL)
Board/Management Information Classification · 98% confidence The document text is very short (828 characters) and announces that the Management Board of Bioton S.A. received declarations from newly appointed Members of the Supervisory Board (Rada Nadzorcza). This constitutes an announcement regarding changes in the company's board of directors or senior management. This directly matches the definition for Board/Management Information (MANG). The legal basis cited is related to ongoing information disclosure requirements, but the core content is personnel change notification.
2019-12-11 Polish
życiorys Pana Wei Ming Tan
Board/Management Information Classification · 98% confidence The provided document text is a detailed curriculum vitae (CV) or resume for an individual named Wei Ming TAN. It outlines professional experience, education, and qualifications, focusing heavily on finance, M&A, investment banking, and executive roles (CFO, Investment Director). This type of document is not a standard regulatory filing (like 10-K, ER, or IR) nor is it an announcement of a filing (like RPA or RNS). It is best classified as general corporate or management information, specifically related to the background of a key executive or board member. Given the definitions, 'Board/Management Information' (MANG) is the most appropriate category for a document detailing the professional history of a senior executive.
2019-12-03 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.